Search

everythinglearnresearchcommunity

for

Search:↓

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

CD2 might be a new treatment target for patchy alopecia areata.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

TNF-alpha inhibitors can cause various immune-related skin issues.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Pantethine may boost the immune system's ability to fight sarcoma.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Autologous platelet concentrates help heal and regenerate dental tissues.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.

Wasabi leaf extract affects gene expression in skin cells.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

NIR-II imaging effectively tracked stem cells that helped repair facial nerve defects in rats.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Mesenchymal stem cells from laser-assisted liposuction are as effective and safe as those from conventional methods for cell therapy.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.